Obsessive Compulsion Disorder (OCD) is a mental health disorder that consists of uncontrollable fears and thoughts that interfere with an individual's everyday life.
The company Neuronetics, who created NeuroStar and was the first FDA approved TMS system, recently received FDA clearance for the use of TMS to treat patients with Obsessive-Compulsion Disorders. This system is a transcranial magnetic stimulation system that uses noninvasive magnetic fields to induce activity in specific localized regions of the brain. This device was previously known and approved for the treatment of treatment resistant depressive disorder. Until recently, the FDA has approved the use of this device to treat Obsessive-Compulsion Disorder (OCD) allowing healthcare providers to treat both OCD and major depressive disorder.
This new approval means TMS could help even more individuals experiencing mental health disorders and reach a greater population.
Read about the recent clearance for OCD here.
